Q4 Earnings Estimate for Cresco Labs Issued By Roth Capital

Cresco Labs Inc. (OTCMKTS:CRLBF) – Stock analysts at Roth Capital issued their Q4 2024 earnings per share (EPS) estimates for shares of Cresco Labs in a research report issued to clients and investors on Sunday, November 10th. Roth Capital analyst W. Kirk expects that the company will post earnings of ($0.01) per share for the quarter. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Roth Capital also issued estimates for Cresco Labs’ Q1 2025 earnings at ($0.01) EPS, Q2 2025 earnings at $0.00 EPS, Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.00 EPS and FY2025 earnings at ($0.01) EPS.

Other analysts have also recently issued research reports about the company. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Ventum Cap Mkts upgraded Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Finally, Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a report on Monday. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $2.50.

Cresco Labs Stock Down 2.8 %

CRLBF opened at $1.40 on Wednesday. The company has a debt-to-equity ratio of 1.76, a current ratio of 2.00 and a quick ratio of 1.30. The stock has a market capitalization of $683.40 million, a price-to-earnings ratio of -7.20 and a beta of 1.88. The business has a 50-day moving average of $1.58 and a two-hundred day moving average of $1.70. Cresco Labs has a 12 month low of $1.02 and a 12 month high of $2.65.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.